MİNİ FLAG+ GO PROTOKOLÜ

Kaynaklar:

1- Borthakur G, Jabbour E, Wang X, et al. Effect of front-line therapy with fludarabine, cytarabine, filgrastim, and gemtuzumab ozogamicin (FLAG-GO) on outcome in core-binding factor associated acute myelogenous leukemia (CBF-AML) ASCO Meeting Abstracts. 2010;28:6552.

2- Larson RA, Boogaerts M, Estey E, et al. Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin) Leukemia. 2002;16:1627–1636.